Oxyle’s vision is to be a global key partner in providing sustainable and efficient wastewater treatment. We have developed novel wastewater treatment reactors capable of destroying over 90% of a wide variety of toxic micropollutants from wastewater effluents, including the highly persistent compounds that are resistant to existing treatments. In contrast to existing technologies, our green approach is highly efficient, cost competitive, uses clean energy sources, and imposes a low carbon footprint.
We will provide modular reactors of varying sizes to meet the cleaning requirements of various customer segments. Decentralized cleaning will be provided with our smallest reactors to industries, hospitals, and research laboratories who are interested in avoiding leakage or intermixing of hazardous wastewater. Centralized cleaning will be provided with our larger reactors to pharmaceutical and biotech companies, hospitals, and wastewater treatment plants who require larger volumes of wastewater to be treated. A patent has been filed in 2018 to protect our invention, and we have already conducted several successful on-site customer pilots using our TRL 6 small-scale prototype.
With EIC accelerator pilot grant we aim to bring our small-scale reactors to market in 2023 and provide our customers with a game-changing wastewater treatment. Our manufacturing partner will produce the reactors and we will manufacture our novel catalyst. Revenue will be generated from a licensing fee and recurring catalyst sales. Our aim is to have 70 operational small-scale reactors providing efficient treatment to eight customers in 2023. In 2026 we will have 5620 operational reactors in all three cleaning sizes and serve 762 global clients to generate 139 M€ in revenue.
Fields of science
Call for proposal
See other projects for this call